Page last updated: 2024-11-12

griseoviridin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

griseoviridin: produced by Streptomyces griseus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11225326
MeSH IDM0056172

Synonyms (12)

Synonym
griseoviridin
53216-90-3
6pm4une85t ,
unii-6pm4une85t
griseoviridin, (-)-
(-)-griseoviridin
griseoviridin [mi]
6,23-dioxa-26-thia-2,17,27-triazatricyclo(17.5.2.14,7)heptacosa-4,7(27),12,14,19-pentaene-3,18,24-trione, 9,11-dihydroxy-22-methyl-, (1s,9r,11s,12e,14e,19z,22r)-
20-o-demethylgriseoviridin c
(1s,9r,11s,12e,14e,19z,22r)-9,11-dihydroxy-22-methyl-6,23-dioxa-26-thia-2,17,27-triazatricyclo[17.5.2.14,7]heptacosa-4,7(27),12,14,19-pentaene-3,18,24-trione
1393-90-4
Q27265286

Research Excerpts

Overview

Griseoviridin (GV) is an A-type streptogramin antibiotic displaying antimicrobial activity. It acts synergistically with viridogrisein (VG)

ExcerptReferenceRelevance
"Griseoviridin (GV) is a broad-spectrum antibiotic with antibacterial and antifungal activity. "( Structural analysis of SgvP involved in carbon-sulfur bond formation during griseoviridin biosynthesis.
Chen, Y; Li, Q; Zhang, G; Zhang, H, 2017
)
2.13
"Griseoviridin (GV) is an A-type streptogramin antibiotic displaying antimicrobial activity and acting synergistically with viridogrisein (VG). "( Involvement of SgvP in carbon-sulfur bond formation during Griseoviridin biosynthesis.
Ju, J; Li, Q; Ma, J; Song, Y; Xie, Y, 2014
)
2.09
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (21.43)18.7374
1990's2 (14.29)18.2507
2000's4 (28.57)29.6817
2010's4 (28.57)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.07 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]